T1201 Maintenance of Remission in Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Trial with Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Maintenance Of Remission

A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis

Journal of Crohn s and Colitis ◽

10.1016/j.crohns.2010.11.004 ◽

2011 ◽

Vol 5 (2) ◽

pp. 115-121 ◽

Cited By ~ 75

Author(s):

Signe Wildt ◽

Inge Nordgaard ◽

Ulla Hansen ◽

Elke Brockmann ◽

Jüri J. Rumessen

Keyword(s):

Ulcerative Colitis ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Maintenance Of Remission

Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial

Journal of Dairy Science ◽

10.3168/jds.2015-10743 ◽

2016 ◽

Vol 99 (7) ◽

pp. 5008-5021 ◽

Cited By ~ 23

Author(s):

Bojana Bogovič Matijašić ◽

Tanja Obermajer ◽

Luka Lipoglavšek ◽

Tjaša Sernel ◽

Igor Locatelli ◽

...

Keyword(s):

Irritable Bowel Syndrome ◽

Controlled Trial ◽

Fermented Milk ◽

Fecal Microbiota ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

A one year, randomised, double blind, placebo controlled trial of probiotics. Bifidobacterium infantis 35624 or Lactobacillus salivarious UCC118, as food supplements for maintenance of remission in Ulcerative colitis.

http://isrctn.org/> ◽

10.1186/isrctn11348435 ◽

2012 ◽

Author(s):

Derek P Jewell

Keyword(s):

Ulcerative Colitis ◽

Controlled Trial ◽

Food Supplements ◽

Bifidobacterium Infantis ◽

Double Blind ◽

Double Blind Placebo ◽

Maintenance Of Remission ◽

One Year

Probiotic treatment of collagenous colitis: A randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis

Inflammatory Bowel Diseases ◽

10.1097/01.mib.0000218763.99334.49 ◽

2006 ◽

Vol 12 (5) ◽

pp. 395-401 ◽

Cited By ~ 51

Author(s):

Signe Wildt ◽

Lars K. Munck ◽

Lars Vinter-Jensen ◽

Birgit Fischer Hanse ◽

Inge Nordgaard-Lassen ◽

...

Keyword(s):

Controlled Trial ◽

Collagenous Colitis ◽

Double Blind ◽

Double Blind Placebo ◽

Probiotic Treatment

Effects of Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Supplementation on Nutritional and Metabolic Parameters in the Early Postoperative Period after Roux-en-Y Gastric Bypass: a Randomized, Double-Blind, Placebo-Controlled Trial

Obesity Surgery ◽

10.1007/s11695-021-05222-2 ◽

2021 ◽

Author(s):

Marília Rizzon Zaparolli Ramos ◽

Lígia de Oliveira Carlos ◽

Nathalia Ramori Farinha Wagner ◽

Ingrid Felicidade ◽

Magda Ramos da Cruz ◽

...

Keyword(s):

Gastric Bypass ◽

Postoperative Period ◽

Controlled Trial ◽

Early Postoperative Period ◽

Metabolic Parameters ◽

Double Blind ◽

Bifidobacterium Lactis ◽

Double Blind Placebo ◽

Lactobacillus Acidophilus Ncfm

Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(21)00400-3 ◽

2021 ◽

Author(s):

Craig Haifer ◽

Sudarshan Paramsothy ◽

Nadeem O Kaakoush ◽

Aiasha Saikal ◽

Simon Ghaly ◽

...

Keyword(s):

Ulcerative Colitis ◽

Controlled Trial ◽

Faecal Microbiota ◽

Double Blind ◽

Double Blind Placebo ◽

Faecal Microbiota Transplantation

Additive factor XIII treatment for severe ulcerative colitis. A double blind placebo-controlled trial

Gastroenterology ◽

10.1016/s0016-5085(98)84125-5 ◽

1998 ◽

Vol 114 ◽

pp. A1014 ◽

Cited By ~ 4

Author(s):

W. Kruis ◽

H. Malchow ◽

M. Behnke ◽

J. Emmrich ◽

J. Hämling ◽

...

Keyword(s):

Ulcerative Colitis ◽

Factor Xiii ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Severe Ulcerative Colitis

Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2006.08.008 ◽

2006 ◽

Vol 4 (12) ◽

pp. 1502-1506 ◽

Cited By ~ 324

Author(s):

Hiroyuki Hanai ◽

Takayuki Iida ◽

Ken Takeuchi ◽

Fumitoshi Watanabe ◽

Yasuhiko Maruyama ◽

...

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis

Alimentary Pharmacology & Therapeutics ◽

10.1046/j.1365-2036.2002.01286.x ◽

2002 ◽

Vol 16 (6) ◽

pp. 1131-1135 ◽

Cited By ~ 46

Author(s):

S. J. Middleton ◽

S. Naylor ◽

J. Woolner ◽

J. O. Hunter

Keyword(s):

Ulcerative Colitis ◽

Fatty Acid ◽

Essential Fatty Acid ◽

Controlled Trial ◽

Double Blind ◽

Fatty Acid Supplementation ◽

Acid Supplementation ◽

Maintenance Of Remission

P081 TREATMENT OF ULCERATIVE COLITIS WITH A COMBINATION OF LACTOBACILLUS RHAMNOSUS AND LACTOBACILLUS ACIDOPHILUS. RESULTS OF A RANDOMISED, DOUBLE-BLIND, AND PLACEBO CONTROLLED TRIAL

Journal of Crohn s and Colitis Supplements ◽

10.1016/s1873-9954(07)70093-9 ◽

2007 ◽

Vol 1 (1) ◽

pp. 24

Author(s):

L. Klinge ◽

J. Kjeldsen ◽

L.A. Chriatensen ◽

J.F. Dahlerup ◽

M. Tvede ◽

...

Keyword(s):

Ulcerative Colitis ◽

Controlled Trial ◽

Lactobacillus Rhamnosus ◽

Double Blind